{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:27:02Z","timestamp":1789846022951,"version":"4.0.1"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,4,4]],"date-time":"2008-04-04T00:00:00Z","timestamp":1207267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2008,4,4]],"date-time":"2008-04-04T00:00:00Z","timestamp":1207267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s12026-008-8016-2","type":"journal-article","created":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T16:55:38Z","timestamp":1207241738000},"page":"123-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies"],"prefix":"10.1007","volume":"41","author":[{"given":"Ifeoma","family":"Okwor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jude","family":"Uzonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,4,4]]},"reference":[{"key":"8016_CR1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-4615-0757-4_15","volume":"512","author":"SL Swain","year":"2002","unstructured":"Swain SL, Agrewala JN, Brown DM, Roman E. Regulation of memory CD4 T cells: generation, localization and persistence. Adv Exp Med Biol. 2002;512:113\u201320.","journal-title":"Adv Exp Med Biol."},{"key":"8016_CR2","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev.immunol.20.100101.151926","volume":"20","author":"J Sprent","year":"2002","unstructured":"Sprent J, Surh CD. T cell memory. Annu Rev Immunol. 2002;20:551\u201379.","journal-title":"Annu Rev Immunol."},{"key":"8016_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.smim.2004.08.013","volume":"16","author":"TS Gourley","year":"2004","unstructured":"Gourley TS, Wherry EJ, Masopust D, Ahmed R. Generation and maintenance of immunological memory. Semin Immunol. 2004;16:323\u201333.","journal-title":"Semin Immunol."},{"key":"8016_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1098\/rstb.2000.0577","volume":"355","author":"JK Whitmire","year":"2000","unstructured":"Whitmire JK, Murali-Krishna K, Altman J, Ahmed R. Antiviral CD4 and CD8 T-cell memory: differences in the size of the response and activation requirements. Philos Trans R Soc Lond B Biol Sci. 2000;355:373\u20139.","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"key":"8016_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.coi.2004.05.013","volume":"16","author":"MK Slifka","year":"2004","unstructured":"Slifka MK. Immunological memory to viral infection. Curr Opin Immunol. 2004;16:443\u201350.","journal-title":"Curr Opin Immunol."},{"key":"8016_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.0300-9475.2004.01460.x","volume":"60","author":"RM Zinkernagel","year":"2004","unstructured":"Zinkernagel RM, Hengartner H. On immunity against infections and vaccines: credo 2004. Scand J Immunol. 2004;60:9\u201313.","journal-title":"Scand J Immunol."},{"key":"8016_CR7","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1098\/rspb.2001.1821","volume":"268","author":"SP Brown","year":"2001","unstructured":"Brown SP, Grenfell BT. An unlikely partnership: parasites, concomitant immunity and host defence. Proc Biol Sci. 2001;268:2543\u20139.","journal-title":"Proc Biol Sci."},{"key":"8016_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/intimm\/dxh005","volume":"16","author":"BJ Manfras","year":"2004","unstructured":"Manfras BJ, Reuter S, Wendland T, Boehm BO, Kern P. Impeded Th1 CD4 memory T cell generation in chronic-persisting liver infection with Echinococcus multilocularis. Int Immunol. 2004;16:43\u201350.","journal-title":"Int Immunol."},{"key":"8016_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1089\/104454903767650676","volume":"22","author":"DA Brake","year":"2003","unstructured":"Brake DA. Parasites and immune responses: memory illusion? DNA Cell Biol. 2003;22:405\u201319.","journal-title":"DNA Cell Biol."},{"key":"8016_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/intimm\/dxh387","volume":"18","author":"MC Albareda","year":"2006","unstructured":"Albareda MC, Laucella SA, Alvarez MG, Armenti AH, Bertochi G, Tarleton RL, Postan M. Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas\u2019 disease patients. Int Immunol. 2006;18:465\u201371.","journal-title":"Int Immunol."},{"key":"8016_CR11","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nrmicro981","volume":"2","author":"P Desjeux","year":"2004","unstructured":"Desjeux P. Leishmaniasis. Nat Rev Microbiol. 2004;2:692.","journal-title":"Nat Rev Microbiol."},{"key":"8016_CR12","first-page":"267","volume":"45","author":"P Desjeux","year":"1992","unstructured":"Desjeux P. Human leishmaniases: epidemiology and public health aspects. World Health Stat Q. 1992;45:267\u201375.","journal-title":"World Health Stat Q."},{"key":"8016_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","volume":"27","author":"P Desjeux","year":"2004","unstructured":"Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27:305\u201318.","journal-title":"Comp Immunol Microbiol Infect Dis."},{"key":"8016_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/00001432-200310000-00005","volume":"16","author":"J Berman","year":"2003","unstructured":"Berman J. Current treatment approaches to leishmaniasis. Curr Opin Infect Dis. 2003;16:397\u2013401.","journal-title":"Curr Opin Infect Dis."},{"key":"8016_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1196\/annals.1307.041","volume":"1026","author":"Y. Vanloubbeeck","year":"2004","unstructured":"Vanloubbeeck Y., Jones DE. The immunology of Leishmania infection and the implications for vaccine development. Ann N Y Acad Sci. 2004;1026:267\u201372.","journal-title":"Ann N Y Acad Sci."},{"key":"8016_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.iy.13.040195.001055","volume":"13","author":"SL Reiner","year":"1995","unstructured":"Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol. 1995;13:151\u201377.","journal-title":"Annu Rev Immunol."},{"key":"8016_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000319481","volume":"63","author":"P Scott","year":"1996","unstructured":"Scott P. Th cell development and regulation in experimental cutaneous leishmaniasis. Chem Immunol. 1996;63:98\u2013114.","journal-title":"Chem Immunol."},{"key":"8016_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/0923-2494(91)90007-6","volume":"142","author":"RM Locksley","year":"1991","unstructured":"Locksley RM, Heinzel FP, Holaday BJ, Mutha SS, Reiner SL, Sadick MD. Induction of Th1 and Th2 CD4+ subsets during murine Leishmania major infection. Res Immunol. 1991;142:28\u201332.","journal-title":"Res Immunol."},{"key":"8016_CR19","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.4049\/jimmunol.154.10.5320","volume":"154","author":"T Scharton-Kersten","year":"1995","unstructured":"Scharton-Kersten T, Afonso LC, Wysocka M, Trinchieri G, Scott P. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J Immunol. 1995;154:5320\u201330.","journal-title":"J Immunol."},{"key":"8016_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1600-065X.1989.tb00557.x","volume":"112","author":"P Scott","year":"1989","unstructured":"Scott P, Pearce E, Cheever AW, Coffman RL, Sher A. Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease. Immunol Rev. 1989;112:161\u201382.","journal-title":"Immunol Rev."},{"key":"8016_CR21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0014-4894(89)90120-3","volume":"68","author":"P Scott","year":"1989","unstructured":"Scott P. The role of Th1 and Th2 cells in experimental cutaneous leishmaniasis. Exp Parasitol. 1989;68:369\u201372.","journal-title":"Exp Parasitol."},{"key":"8016_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1126\/science.7904381","volume":"263","author":"LC Afonso","year":"1994","unstructured":"Afonso LC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G, Scott P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science. 1994;263:235\u20137.","journal-title":"Science."},{"key":"8016_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1046\/j.1365-3083.2001.00917.x","volume":"53","author":"AY Park","year":"2001","unstructured":"Park AY, Scott P. Il-12: keeping cell-mediated immunity alive. Scand J Immunol. 2001;53:529\u201332.","journal-title":"Scand J Immunol."},{"key":"8016_CR24","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1128\/IAI.66.8.3818-3824.1998","volume":"66","author":"D Jones","year":"1998","unstructured":"Jones D, Elloso MM, Showe L, Williams D, Trinchieri G, Scott P. Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major. Infect Immun. 1998;66:3818\u201324.","journal-title":"Infect Immun."},{"key":"8016_CR25","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.4049\/jimmunol.161.11.6156","volume":"161","author":"H Himmelrich","year":"1998","unstructured":"Himmelrich H, Parra-Lopez C, Tacchini-Cottier F, Louis JA, Launois P. The IL-4 rapidly produced in BALB\/c mice after infection with Leishmania major down-regulates IL-12 receptor beta 2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12. J Immunol. 1998;161:6156\u201363.","journal-title":"J Immunol."},{"key":"8016_CR26","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0952-7915(98)80121-0","volume":"10","author":"J Louis","year":"1998","unstructured":"Louis J, Himmelrich H, Parra-Lopez C, Tacchini-Cottier F, Launois P. Regulation of protective immunity against Leishmania major in mice. Curr Opin Immunol. 1998;10:459\u201364.","journal-title":"Curr Opin Immunol."},{"key":"8016_CR27","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4049\/jimmunol.166.2.1141","volume":"166","author":"MM Kane","year":"2001","unstructured":"Kane MM, Mosser DM. The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol. 2001;166:1141\u20137.","journal-title":"J Immunol."},{"key":"8016_CR28","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.4049\/jimmunol.162.3.1723","volume":"162","author":"H Groux","year":"1999","unstructured":"Groux H, Cottrez F, Rouleau M, Mauze S, Antonenko S, Hurst S, McNeil T, Bigler M, Roncarolo MG, Coffman RL. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J Immunol. 1999;162:1723\u20139.","journal-title":"J Immunol."},{"key":"8016_CR29","doi-asserted-by":"publisher","first-page":"A49","DOI":"10.1016\/S0167-5699(05)80015-5","volume":"12","author":"TR Mosmann","year":"1991","unstructured":"Mosmann TR, Moore KW. The role of IL-10 in cross-regulation of Th1 and Th2 responses. Immunol Today. 1991;12:A49\u201353.","journal-title":"Immunol Today."},{"key":"8016_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1365-3024.1999.00224.x","volume":"21","author":"R Chatelain","year":"1999","unstructured":"Chatelain R, Mauze S, Coffman RL. Experimental Leishmania major infection in mice: role of IL-10. Parasite Immunol. 1999;21:211\u20138.","journal-title":"Parasite Immunol."},{"key":"8016_CR31","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1517\/14712598.3.6.875","volume":"3","author":"Y Belkaid","year":"2003","unstructured":"Belkaid Y. The role of CD4+CD25+ regulatory T cells in Leishmania infection. Expert Opin Biol Ther. 2003;3:875\u201385.","journal-title":"Expert Opin Biol Ther."},{"key":"8016_CR32","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nature01152","volume":"420","author":"Y Belkaid","year":"2002","unstructured":"Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature. 2002;420:502\u20137.","journal-title":"Nature."},{"key":"8016_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1286-4579(99)80016-1","volume":"1","author":"B Hondowicz","year":"1999","unstructured":"Hondowicz B, Scott P. Influence of host and parasite factors on the innate immune response and Th2 stability following infection with Leishmania major. Microbes Infect. 1999;1:65\u201371.","journal-title":"Microbes Infect."},{"key":"8016_CR34","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.ijpara.2003.11.021","volume":"34","author":"A Gumy","year":"2004","unstructured":"Gumy A, Louis JA, Launois P. The murine model of infection with Leishmania major and its importance for the deciphering of mechanisms underlying differences in Th cell differentiation in mice from different genetic backgrounds. Int J Parasitol. 2004;34:433\u201344.","journal-title":"Int J Parasitol."},{"key":"8016_CR35","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.micinf.2004.05.024","volume":"6","author":"E von Stebut","year":"2004","unstructured":"von Stebut E, Udey MC. Requirements for Th1-dependent immunity against infection with Leishmania major. Microbes Infect. 2004;6:1102\u20139.","journal-title":"Microbes Infect."},{"key":"8016_CR36","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nri933","volume":"2","author":"D Sacks","year":"2002","unstructured":"Sacks D, Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol. 2002;2:845\u201358.","journal-title":"Nat Rev Immunol."},{"key":"8016_CR37","first-page":"377","volume":"76","author":"A Nadim","year":"1983","unstructured":"Nadim A, Javadian E, Tahvildar-Bidruni G, Ghorbani M. Effectiveness of leishmanization in the control of cutaneous leishmaniasis. Bull Soc Pathol Exot Filiales. 1983;76:377\u201383.","journal-title":"Bull Soc Pathol Exot Filiales."},{"issue":"Suppl","key":"8016_CR38","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1017\/S0031182000072243","volume":"98","author":"F Modabber","year":"1989","unstructured":"Modabber F. Experiences with vaccines against cutaneous leishmaniasis: of men and mice. Parasitology. 1989;98 Suppl:S49\u201360.","journal-title":"Parasitology."},{"key":"8016_CR39","first-page":"648","volume":"37","author":"EE Shuikina","year":"1968","unstructured":"Shuikina EE, Sergiev VP, Triers II, Shcherbakov VA, Diveev S. [Experience of antileishmaniasis vaccinations with cultures of Leishmania tropica major grown in various types of media]. Med Parazitol (Mosk). 1968;37:648\u201351.","journal-title":"Med Parazitol (Mosk)."},{"key":"8016_CR40","first-page":"541","volume":"39","author":"PG Sergiev","year":"1970","unstructured":"Sergiev PG, Beislekhem RI, Moshkovskii, ShD, Demina NA, Kellina OI. Results of massive vaccination against zoonotic cutaneous leishmaniasis. Med Parazitol (Mosk). 1970;39:541\u201351.","journal-title":"Med Parazitol (Mosk)."},{"key":"8016_CR41","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1016\/j.vaccine.2005.02.015","volume":"23","author":"A Khamesipour","year":"2005","unstructured":"Khamesipour A, Dowlati Y, Asilian A, Hashemi-Fesharki R, Javadi A, Noazin S, Modabber F. Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis. Vaccine. 2005;23:3642\u20138.","journal-title":"Vaccine."},{"key":"8016_CR42","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1002\/eji.1830221206","volume":"22","author":"I Muller","year":"1992","unstructured":"Muller I. Role of T cell subsets during the recall of immunologic memory to Leishmania major. Eur J Immunol. 1992;22:3063\u20139.","journal-title":"Eur J Immunol."},{"key":"8016_CR43","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1128\/iai.61.9.3730-3738.1993","volume":"61","author":"I Muller","year":"1993","unstructured":"Muller I, Kropf P, Etges RJ, Louis JA. Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells. Infect Immun. 1993;61:3730\u20138.","journal-title":"Infect Immun."},{"key":"8016_CR44","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4049\/jimmunol.165.2.896","volume":"165","author":"AY Park","year":"2000","unstructured":"Park AY, Hondowicz BD, Scott P. IL-12 is required to maintain a Th1 response during Leishmania major infection. J Immunol. 2000;165:896\u2013902.","journal-title":"J Immunol."},{"key":"8016_CR45","doi-asserted-by":"publisher","first-page":"8427","DOI":"10.1073\/pnas.160197797","volume":"97","author":"L Stobie","year":"2000","unstructured":"Stobie L, Gurunathan S, Prussin C, Sacks DL, Glaichenhaus N, Wu CY, Seder RA. The role of antigen and IL-12 in sustaining Th1 memory cells in\u00a0vivo: IL-12 is required to maintain memory\/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge. Proc Natl Acad Sci USA. 2000;97:8427\u201332.","journal-title":"Proc Natl Acad Sci USA."},{"key":"8016_CR46","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.4049\/jimmunol.168.11.5771","volume":"168","author":"AY Park","year":"2002","unstructured":"Park AY, Hondowicz B, Kopf M, Scott P. The role of IL-12 in maintaining resistance to Leishmania major. J Immunol. 2002;168:5771\u20137.","journal-title":"J Immunol."},{"key":"8016_CR47","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/nm1108","volume":"10","author":"C Zaph","year":"2004","unstructured":"Zaph C, Uzonna J, Beverley SM, Scott P. Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat Med. 2004;10:1104\u201310.","journal-title":"Nat Med."},{"key":"8016_CR48","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1111\/j.1462-5822.2005.00626.x","volume":"7","author":"P Scott","year":"2005","unstructured":"Scott P. Immunologic memory in cutaneous leishmaniasis. Cell Microbiol. 2005;7:1707\u201313.","journal-title":"Cell Microbiol."},{"key":"8016_CR49","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.0105-2896.2004.00198.x","volume":"201","author":"P Scott","year":"2004","unstructured":"Scott P, Artis D, Uzonna J, Zaph C. The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development. Immunol Rev. 2004;201:318\u201338.","journal-title":"Immunol Rev."},{"key":"8016_CR50","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.4049\/jimmunol.167.12.6967","volume":"167","author":"JE Uzonna","year":"2001","unstructured":"Uzonna JE, Wei G, Yurkowski D, Bretscher P. Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease. J Immunol. 2001;167:6967\u201374.","journal-title":"J Immunol."},{"key":"8016_CR51","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1084\/jem.20052056","volume":"203","author":"IJ Suffia","year":"2006","unstructured":"Suffia IJ, Reckling SK, Piccirillo CA, Goldszmid RS, Belkaid Y. Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J Exp Med. 2006;203:777\u201388.","journal-title":"J Exp Med."},{"key":"8016_CR52","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1146\/annurev.immunol.16.1.201","volume":"16","author":"RW Dutton","year":"1998","unstructured":"Dutton RW, Bradley LM, Swain SL. T cell memory. Annu Rev Immunol. 1998;16:201\u201323.","journal-title":"Annu Rev Immunol."},{"key":"8016_CR53","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1084\/jem.174.5.969","volume":"174","author":"D Gray","year":"1991","unstructured":"Gray D, Matzinger P. T cell memory is short-lived in the absence of antigen. J Exp Med. 1991;174:969\u201374.","journal-title":"J Exp Med."},{"key":"8016_CR54","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","volume":"22","author":"F Sallusto","year":"2004","unstructured":"Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol. 2004;22:745\u201363.","journal-title":"Annu Rev Immunol."},{"key":"8016_CR55","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S1471-4906(03)00169-8","volume":"24","author":"DF Tough","year":"2003","unstructured":"Tough DF. Deciphering the relationship between central and effector memory CD8+ T cells. Trends Immunol. 2003;24:404\u20137.","journal-title":"Trends Immunol."},{"key":"8016_CR56","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/44385","volume":"401","author":"F Sallusto","year":"1999","unstructured":"Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401:708\u201312.","journal-title":"Nature."},{"key":"8016_CR57","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1172\/JCI200114005","volume":"108","author":"F Sallusto","year":"2001","unstructured":"Sallusto F, Lanzavecchia A. Exploring pathways for memory T cell generation. J Clin Invest. 2001;108:805\u20136.","journal-title":"J Clin Invest."},{"key":"8016_CR58","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ni889","volume":"4","author":"EJ Wherry","year":"2003","unstructured":"Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM, Antia R, von Andrian UH, Ahmed R. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol. 2003;4:225\u201334.","journal-title":"Nat Immunol."},{"key":"8016_CR59","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/87720","volume":"2","author":"SM Kaech","year":"2001","unstructured":"Kaech SM, Ahmed R. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat Immunol. 2001;2:415\u201322.","journal-title":"Nat Immunol."},{"key":"8016_CR60","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/35065111","volume":"410","author":"RL Reinhardt","year":"2001","unstructured":"Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK. Visualizing the generation of memory CD4 T cells in the whole body. Nature. 2001;410:101\u20135.","journal-title":"Nature."},{"key":"8016_CR61","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/iai.61.1.220-226.1993","volume":"61","author":"T Aebischer","year":"1993","unstructured":"Aebischer T, Moody SF, Handman E. Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host. Infect Immun. 1993;61:220\u20136.","journal-title":"Infect Immun."},{"key":"8016_CR62","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0169-4758(94)90353-0","volume":"10","author":"T Aebischer","year":"1994","unstructured":"Aebischer T. Recurrent cutaneous leishmaniasis: a role for persistent parasites? Parasitol Today. 1994;10:25\u20138.","journal-title":"Parasitol Today."},{"key":"8016_CR63","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0035-9203(95)90497-2","volume":"89","author":"N Berhe","year":"1995","unstructured":"Berhe N, Hailu A, Wolday D, Negesse Y, Cenini P, Frommel D. Ethiopian visceral leishmaniasis patients co-infected with human immunodeficiency virus. Trans R Soc Trop Med Hyg. 1995;89:205\u20137.","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"8016_CR64","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0169-4758(99)01431-3","volume":"15","author":"D. Wolday","year":"1999","unstructured":"Wolday D., Berhe N, Akuffo H, Britton S. Leishmania-HIV interaction: immunopathogenic mechanisms. Parasitol Today. 1999;15:182\u20137.","journal-title":"Parasitol Today."},{"key":"8016_CR65","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s004300100082","volume":"190","author":"D Wolday","year":"2001","unstructured":"Wolday D, Berhe N, Akuffo H, Desjeux P, Britton S. Emerging Leishmania\/HIV co-infection in Africa. Med Microbiol Immunol. (Berl) 2001;190:65\u20137.","journal-title":"Med Microbiol Immunol (Berl)."},{"key":"8016_CR66","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/0140-6736(90)91945-7","volume":"336","author":"NG Saravia","year":"1990","unstructured":"Saravia NG, Weigle K, Segura I, Giannini SH, Pacheco R, Labrada LA, Goncalves A. Recurrent lesions in human Leishmania braziliensis infection-reactivation or reinfection? Lancet. 1990;336:398\u2013402.","journal-title":"Lancet."},{"key":"8016_CR67","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1084\/jem.183.4.1501","volume":"183","author":"S Stenger","year":"1996","unstructured":"Stenger S, Donhauser N, Thuring H, Rollinghoff M, Bodgan C. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med. 1996;183:1501\u201314.","journal-title":"J Exp Med."},{"key":"8016_CR68","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1084\/jem.20040298","volume":"200","author":"S Mendez","year":"2004","unstructured":"Mendez S, Reckling SK, Piccirillo CA, Sacks D, Belkaid Y. Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med. 2004;200:201\u201310.","journal-title":"J Exp Med."},{"key":"8016_CR69","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1002\/1521-4141(200111)31:11<3175::AID-IMMU3175>3.0.CO;2-L","volume":"31","author":"JE Uzonna","year":"2001","unstructured":"Uzonna JE, Bretscher PA. Anti-IL-4 antibody therapy causes regression of chronic lesions caused by medium-dose Leishmania major infection in BALB\/c mice. Eur J Immunol. 2001;31:3175\u201384.","journal-title":"Eur J Immunol."},{"key":"8016_CR70","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1086\/502980","volume":"193","author":"AP Campanelli","year":"2006","unstructured":"Campanelli AP, Roselino AM, Cavassani KA, Pereira MS, Mortara RA, Brodskyn CI, Goncalves HS, Belkaid Y, Barral-Netto M, Barral A, Silva JS. CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J Infect Dis. 2006;193:1313\u201322.","journal-title":"J Infect Dis."},{"key":"8016_CR71","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1086\/324665","volume":"184","author":"E Bourreau","year":"2001","unstructured":"Bourreau E, Prevot G, Gardon J, Pradinaud R, Launois P. High intralesional interleukin-10 messenger RNA expression in localized cutaneous leishmaniasis is associated with unresponsiveness to treatment. J Infect Dis. 2001;184:1628\u201330.","journal-title":"J Infect Dis."},{"key":"8016_CR72","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1046\/j.1365-3083.2001.00990.x","volume":"54","author":"GR Habibi","year":"2001","unstructured":"Habibi GR, Khamesipour A, McMaster WR, Mahboudi F. Cytokine gene expression in healing and non-healing cases of cutaneous leishmaniasis in response to in vitro stimulation with recombinant gp63 using semi-quantitative RT-PCR. Scand J Immunol. 2001;54:414\u201320.","journal-title":"Scand J Immunol."},{"key":"8016_CR73","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1126\/science.1087499","volume":"301","author":"GF Spath","year":"2003","unstructured":"Spath GF, Lye LF, Segawa H, Sacks DL, Turco SJ, Beverley SM. Persistence Without Pathology in Phosphoglycan-Deficient Leishmania major. Science. 2003;301:1241\u20133.","journal-title":"Science."},{"key":"8016_CR74","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/369648a0","volume":"369","author":"LL Lau","year":"1994","unstructured":"Lau LL, Jamieson BD, Somasundaram T, Ahmed R. Cytotoxic T-cell memory without antigen. Nature. 1994;369:648\u201352.","journal-title":"Nature."},{"key":"8016_CR75","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1098\/rstb.2000.0581","volume":"355","author":"SL Swain","year":"2000","unstructured":"Swain SL. CD4 T-cell memory can persist in the absence of class II. Philos Trans R Soc Lond B Biol Sci. 2000;355:407\u201311.","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"key":"8016_CR76","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nri706","volume":"2","author":"D Gray","year":"2002","unstructured":"Gray D. A role for antigen in the maintenance of immunological memory. Nat Rev Immunol. 2002;2:60\u20135.","journal-title":"Nat Rev Immunol."},{"key":"8016_CR77","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0952-7915(02)00367-9","volume":"14","author":"RM Zinkernagel","year":"2002","unstructured":"Zinkernagel RM. On differences between immunity and immunological memory. Curr Opin Immunol. 2002;14:523\u201336.","journal-title":"Curr Opin Immunol."},{"key":"8016_CR78","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.4049\/jimmunol.168.9.4455","volume":"168","author":"EJ Wherry","year":"2002","unstructured":"Wherry EJ, McElhaugh MJ, Eisenlohr LC. Generation of CD8(+) T cell memory in response to low, high, and excessive levels of epitope. J Immunol. 2002;168:4455\u201361.","journal-title":"J Immunol."},{"key":"8016_CR79","first-page":"429","volume":"41","author":"GV Brown","year":"1999","unstructured":"Brown GV. Progress in the development of malaria vaccines: context and constraints. Parassitologia. 1999;41:429\u201332.","journal-title":"Parassitologia."},{"key":"8016_CR80","first-page":"45","volume":"33","author":"J Andreassen","year":"1991","unstructured":"Andreassen J. Immunity to adult cestodes: basic knowledge and vaccination problems. A review. Parassitologia. 1991;33:45\u201353.","journal-title":"Parassitologia."},{"key":"8016_CR81","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1645\/GE-3507.1","volume":"92","author":"S Rajakumar","year":"2006","unstructured":"Rajakumar S, Bleiss W, Hartmann S, Schierack P, Marko A, Lucius R. Concomitant immunity in a rodent model of filariasis: the infection of Meriones unguiculatus with Acanthocheilonema viteae. J Parasitol. 2006;92:41\u20135.","journal-title":"J Parasitol."},{"key":"8016_CR82","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.0105-2896.2004.00181.x","volume":"201","author":"SS Struik","year":"2004","unstructured":"Struik SS, Riley EM. Does malaria suffer from lack of memory? Immunol Rev. 2004;201:268\u201390.","journal-title":"Immunol Rev."},{"key":"8016_CR83","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.4049\/jimmunol.174.5.2934","volume":"174","author":"CF Anderson","year":"2005","unstructured":"Anderson CF, Mendez S, Sacks DL. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL\/6 mice. J Immunol. 2005;174:2934\u201341.","journal-title":"J Immunol."},{"key":"8016_CR84","doi-asserted-by":"publisher","first-page":"10267","DOI":"10.1073\/pnas.92.22.10267","volume":"92","author":"RG Titus","year":"1995","unstructured":"Titus RG, Gueiros-Filho FJ, de Freitas LA, Beverley SM. Development of a safe live Leishmania vaccine line by gene replacement. Proc Natl Acad Sci USA. 1995;92:10267\u201371.","journal-title":"Proc Natl Acad Sci USA."},{"key":"8016_CR85","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.4049\/jimmunol.172.6.3793","volume":"172","author":"JE Uzonna","year":"2004","unstructured":"Uzonna JE, Spath GF, Beverley SM, Scott P. Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response. J Immunol. 2004;172:3793\u20137.","journal-title":"J Immunol."},{"issue":"Suppl 1","key":"8016_CR86","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/00034983.1995.11813017","volume":"89","author":"F Modabber","year":"1995","unstructured":"Modabber F. Vaccines against leishmaniasis. Ann Trop Med Parasitol. 1995;89(Suppl 1):83\u20138.","journal-title":"Ann Trop Med Parasitol."},{"key":"8016_CR87","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1590\/S0074-02761998000200014","volume":"93","author":"KB Marzochi","year":"1998","unstructured":"Marzochi KB, Marzochi MA, Silva AF, Grativol N, Duarte R, Confort EM, Modabber F. Phase 1 study of an inactivated vaccine against American tegumentary leishmaniasis in normal volunteers in Brazil. Mem Inst Oswaldo Cruz. 1998;93:205\u201312.","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"8016_CR88","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/S0140-6736(98)09552-X","volume":"351","author":"I Sharifi","year":"1998","unstructured":"Sharifi I, FeKri AR, Aflatonian MR, Khamesipour A, Nadim A, Mousavi MR, Momeni AZ, Dowlati Y, Godal T, Zicker F, Smith PG, Modabber F. Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran. Lancet. 1998;351:1540\u20133.","journal-title":"Lancet."},{"key":"8016_CR89","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S0264-410X(98)00220-5","volume":"17","author":"AZ Momeni","year":"1999","unstructured":"Momeni AZ, Jalayer T, Emamjomeh M, Khamesipour A, Zicker F, Ghassemi RL, Dowlati Y, Sharifi I, Aminjavaheri M, Shafiei A, Alimohammadian MH, Hashemi-Fesharki R, Nasseri K, Godal T, Smith PG, Modabber F. A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran. Vaccine. 1999;17:466\u201372.","journal-title":"Vaccine."},{"key":"8016_CR90","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S0035-9203(00)90239-6","volume":"94","author":"ID Velez","year":"2000","unstructured":"Velez ID, del Pilar Agudelo S, Arbelaez MP, Gilchrist K, Robledo SM, Puerta JA, Zicker F, Berman J, Modabber F. Safety and immunogenicity of a killed Leishmania (L.) amazonensis vaccine against cutaneous leishmaniasis in Colombia: a randomized controlled trial. Trans R Soc Trop Med Hyg. 2000;94:698\u2013703.","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"8016_CR91","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(00)03128-7","volume":"356","author":"EA Khalil","year":"2000","unstructured":"Khalil EA, El Hassan AM, Zijlstra EE, Mukhtar MM, Ghalib HW, Musa B, Ibrahim ME, Kamil AA, Elsheikh M, Babiker A, Modabber F. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan. Lancet.  2000;356:1565\u20139.","journal-title":"Lancet."},{"key":"8016_CR92","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1046\/j.1365-2249.2003.02299.x","volume":"134","author":"M Mahmoodi","year":"2003","unstructured":"Mahmoodi M, Khamesipour A, Dowlati Y, Rafati S, Momeni AZ, Emamjomeh M, Hejazi H, Modabber F. Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG. Clin Exp Immunol. 2003;134:303\u20138.","journal-title":"Clin Exp Immunol."},{"key":"8016_CR93","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.vaccine.2003.06.002","volume":"22","author":"RX Armijos","year":"2004","unstructured":"Armijos RX, Weigel MM, Calvopina M, Hidalgo A, Cevallos W, Correa J. Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis. Vaccine. 2004;22:1320\u20136.","journal-title":"Vaccine."},{"key":"8016_CR94","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1084\/jem.186.7.1137","volume":"186","author":"S Gurunathan","year":"1997","unstructured":"Gurunathan S, Sacks DL, Brown DR, Reiner SL, Charest H, Glaichenhaus N, Seder RA. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J Exp Med. 1997;186:1137\u201347.","journal-title":"J Exp Med."},{"key":"8016_CR95","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/icb.1983.2","volume":"61","author":"GF Mitchell","year":"1983","unstructured":"Mitchell GF, Handman E. Leishmania tropica major in mice: vaccination against cutaneous leishmaniasis in mice of high genetic susceptibility. Aust J Exp Biol Med Sci. 1983;61:11\u201325.","journal-title":"Aust J Exp Biol Med Sci."},{"key":"8016_CR96","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1016\/S0264-410X(00)00109-2","volume":"18","author":"E Handman","year":"2000","unstructured":"Handman E, Noormohammadi AH, Curtis JM, Baldwin T, Sjolander A. Therapy of murine cutaneous leishmaniasis by DNA vaccination. Vaccine. 2000;18:3011\u20137.","journal-title":"Vaccine."},{"key":"8016_CR97","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/S0264-410X(00)00339-X","volume":"19","author":"VO da Silva","year":"2000","unstructured":"da Silva VO, Borja-Cabrera GP, Correia Pontes NN, de Souza EP, Luz KG, Palatnik M, Palatnik de Sousa CB. A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN). Vaccine. 2000;19:1082\u201392.","journal-title":"Vaccine."},{"key":"8016_CR98","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1128\/IAI.68.3.1328-1336.2000","volume":"68","author":"T Aebischer","year":"2000","unstructured":"Aebischer T, Wolfram M, Patzer SI, Ilg T, Wiese M, Overath P. Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants. Infect Immun. 2000;68:1328\u201336.","journal-title":"Infect Immun."},{"key":"8016_CR99","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.4049\/jimmunol.165.12.7064","volume":"165","author":"S Stager","year":"2000","unstructured":"Stager S, Smith DF, Kaye PM. Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis. J Immunol. 2000;165:7064\u201371.","journal-title":"J Immunol."},{"key":"8016_CR100","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.vaccine.2003.10.046","volume":"22","author":"SB Ahmed","year":"2004","unstructured":"Ahmed SB, Bahloul C, Robbana C, Askri S, Dellagi K. A comparative evaluation of different DNA vaccine candidates against experimental murine leishmaniasis due to L. major. Vaccine. 2004;22:1631\u20139.","journal-title":"Vaccine."},{"key":"8016_CR101","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1046\/j.1365-2133.1999.03169.x","volume":"141","author":"DA Vardy","year":"1999","unstructured":"Vardy DA, Cohen A, Kachko L, Zvulunov A, Frankenburg S. Relapse of cutaneous leishmaniasis in a patient with an infected subcutaneous rheumatoid nodule. Br J Dermatol. 1999;141:914\u20137.","journal-title":"Br J Dermatol."},{"key":"8016_CR102","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1128\/IAI.74.1.777-780.2006","volume":"74","author":"C Kebaier","year":"2006","unstructured":"Kebaier C, Uzonna JE, Beverley SM, Scott P. Immunization with persistent attenuated Delta lpg2 Leishmania major parasites requires adjuvant to provide protective immunity in C57BL\/6 mice. Infect Immun. 2006;74:777\u201380.","journal-title":"Infect Immun."},{"key":"8016_CR103","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1590\/S0074-02761999000400011","volume":"94","author":"P Veras","year":"1999","unstructured":"Veras P, Brodskyn C, Balestieri F, Ld F, Ramos A, Queiroz A, Barral A, Beverley S, Barral-Netto M. A dhfr-ts- leishmania major knockout mutant cross-protects against leishmania amazonensis [In Process Citation]. Mem Inst Oswaldo Cruz. 1999;94:491\u20136.","journal-title":"Mem Inst Oswaldo Cruz."}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-008-8016-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-008-8016-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-008-8016-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-008-8016-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:28:54Z","timestamp":1744147734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-008-8016-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,4]]},"references-count":103,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["8016"],"URL":"https:\/\/doi.org\/10.1007\/s12026-008-8016-2","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,4]]},"assertion":[{"value":"4 April 2008","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}